60 to 70% of medical decisions are made based on a result from a biological diagnostic test. ** Discover exclusively our new range of medical equipment to diagnose diabetes with Roche Diagnostics .
Biological (or in vitro ) diagnosis brings together all the techniques, apparatus and devices which make it possible to obtain medical information from a sample of blood, urine or tissue taken from patients.
The pharmaceutical activity, led in France by Roche Pharma aims to treat and cure, by developing and marketing new treatments for pathologies where the medical needs are not yet satisfied: in cancerology, in immunotherapy, in neurosciences and in diseases. rare.
All stages of our R&D are represented in France: from the early stages of development, particularly in translational research with the creation of the Roche Institute in 2011, to clinical development with more than 17,000 patients included in our 252 clinical studies in 2020. Roche leads many projects to support patients throughout their care and life journey. Roche Pharma France's head office is located in Boulogne-Billancourt, in the Paris region. It accommodates administrative, marketing, medical and regulatory functions;
Roche Diabetes Care is the world leader in self-monitoring blood glucose levels and a leader in diabetes management systems and services. Through its Accu-Chek ® and RocheDiabetes brands, Roche Diabetes Care offers patients and healthcare professionals a full range of products, solutions and services to help better manage diabetes. Fully committed to the digitalization of medicine and the care pathway (particularly in its telemonitoring component), Roche Diabetes Care France offers blood glucose meters and insulin pumps, as well as tools and services, digital or physical, to help each individual. patient to manage their diabetes as calmly as possible and support healthcare professionals in their actions with patients.
Roche Diabetes Care France is based in Montbonnot-Saint-Martin, near Grenoble (Isère).
